|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation | |||||
| Amortization of intangible assets | |||||
| Impairment of intangible assets | |||||
| Loss on investments | |||||
| Share-based compensation expense | |||||
| Deferred income taxes | |||||
| Change in fair value of contingent consideration for business acquisition | |||||
| Pension curtailment gains | |||||
| Other | |||||
| Changes in assets and liabilities, net of acquisitions: | |||||
| Accounts receivable, net | |||||
| Inventories | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accrued and other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of property, plant and equipment | |||||
| Acquisitions, net of cash acquired | |||||
| Purchases of short-term investments | |||||
| Proceeds from the sale of short-term investments | |||||
| Purchases of deferred compensation investments | |||||
| Proceeds from sales of deferred compensation investments | |||||
| Other investing activities | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Payment of cash dividends | |||||
| Payment of contingent consideration for business acquisition | |||||
| Purchases of registered shares | |||||
| Proceeds from exercises of stock options and purchase rights | |||||
| Tax withholdings related to net share settlements of restricted stock units | |||||
| Other financing activities | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of the period | |||||
| Cash and cash equivalents at end of the period | |||||
| Supplementary Cash Flow Disclosures: | |||||
| Non-cash investing and financing activities: | |||||
| Property, plant and equipment purchased during the period and included in period end liability accounts | |||||
| Fair value of contingent consideration in accrued and other liabilities | |||||
| Supplemental cash flow information: | |||||
| Income taxes paid, net | |||||
Loading...